Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aptose Biosciences (GB:0UI8)
LSE:0UI8
Holding GB:0UI8?
Track your performance easily
0UI8 Stock Chart & Stats
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 07, 2023EPS Estimate
-C$2.81Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$26.96Price Target Upside― Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Aptose Biosciences News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
13.24% Other Institutional Investors
86.76% Public Companies and
Individual Investors
0UI8 FAQ
What was Aptose Biosciences’s price range in the past 12 months?
Currently, no data Available
What is Aptose Biosciences’s market cap?
Currently, no data Available
When is Aptose Biosciences’s upcoming earnings report date?
Aptose Biosciences’s upcoming earnings report date is Nov 07, 2023 which is 411 days ago.
How were Aptose Biosciences’s earnings last quarter?
Aptose Biosciences released its earnings results on Aug 10, 2023. The company reported -C$3.105 earnings per share for the quarter, missing the consensus estimate of -C$2.716 by -C$0.388.
Is Aptose Biosciences overvalued?
According to Wall Street analysts Aptose Biosciences’s price is currently Undervalued.
Does Aptose Biosciences pay dividends?
Aptose Biosciences does not currently pay dividends.
What is Aptose Biosciences’s EPS estimate?
Aptose Biosciences’s EPS estimate is -C$2.81.
How many shares outstanding does Aptose Biosciences have?
Currently, no data Available
What happened to Aptose Biosciences’s price movement after its last earnings report?
Aptose Biosciences reported an EPS of -C$3.105 in its last earnings report, missing expectations of -C$2.716. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Aptose Biosciences?
Among the largest hedge funds holding Aptose Biosciences’s share is Carlson Capital LP. It holds Aptose Biosciences’s shares valued at 495K.
---
Aptose Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$26.96 (― Upside)
C$26.96 (― Upside)
Blogger Sentiment
Neutral
GB:0UI8 Sentiment 50%
Sector Average 67%
Sector Average 67%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-64.89%
12-Months-Change
Fundamentals
Return on Equity
-137.37%
Trailing 12-Months
Asset Growth
-58.99%
Trailing 12-Months
Company Description
Aptose Biosciences
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
---
0UI8 Stock 12 Month Forecast
Average Price Target
―Aptose Biosciences
―
Arrowhead Pharmaceuticals
―
Corbus Pharmaceuticals
―
G1 Therapeutics
―
Kura Oncology
―
Best Analysts Covering 0UI8
1 Year
1 Year Success Rate
5/18 ratings generated profit
1 Year Average Return
+1.42%
initiated a buy rating 2 years ago
Copying John Newman's trades and holding each position for 1 Year would result in 27.78% of your transactions generating a profit, with an average return of +1.42% per trade.
---